Avalo Therapeutics, Inc. · NASDAQ:AVTX

Riley Jennifer received 34,200 Avalo Therapeutics, Inc. shares as an award (Form 4)

Traded May 21, 2026 · Filed May 26, 2026

On May 21, 2026, Riley Jennifer (Chief Strategy Officer) received 34,200 Avalo Therapeutics, Inc. shares as an award, leaving 36,855 shares. Filed May 26, 2026 (Form 4).

Awarded: 34,200 shares
Holding after: 36,855 shares
Trading plan: No
Role: Chief Strategy Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
May 21, 2026	Common Stock	Award	34,200		36,855	Direct

Source

View original at SEC

Related